1 to 9 of 20 results

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis


There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals

Fabiana Lacerca joins Mylan as its senior VP and chief compliance officer


Fabiana Lacerca has joined US drugmaker Mylan Laboratories as senior vice president and chief compliance…

Bristol-Myers SquibbMylan Laboratories

B-MS and Somerset in Emsam distribution deal


US drug major Bristol-Myers Squibb and Somerset Pharmaceuticals, a joint venture between Mylan Laboratories…

Bristol-Myers SquibbEmsamMylan LaboratoriesSelegiline Transdermal SystemTestosteronetransdermalWatson Pharmaceuticals

Teva stays ahead of the pack with $3.4 billion Sicor acquisition


Israel's Teva Pharmaceutical has moved to consolidate its position asthe world's leading generics manufacturer…

AstraZenecaBristol-Myers SquibbCopaxoneFluoxetine HclGlatiramer AcetateLillyMerck KGaAMylan LaboratoriesNovartisNystatinOmeprazoleOralPrilosecProzacWatson Pharmaceuticals

Mylan reaches buspirone settlement with B-MS


US generic drugmaker Mylan Laboratories has reached a final agreementwith Bristol-Myers Squibb which,…

Bristol-Myers SquibbBusparBuspironeMylan Laboratories

Abbott, NaPro get OK for generic Taxol in USA


Abbott Laboratories and NaPro BioTherapeutics are set to become thelatest suppliers of a generic form…

Abbott LaboratoriesAmino AcidsBristol-Myers SquibbInjectionIvaxMylan LaboratoriesPaclitaxelPhysostigmine SalicylateTaxol

Mylan becomes second firm to offer generic paclitaxel in the USA


Mylan Laboratories has been granted marketing approval from the US Foodand Drug Administration for its…

Abbott LaboratoriesAmino AcidsBristol-Myers SquibbInjectionIvaxMylan LaboratoriesPaclitaxelPhysostigmine SalicylateTaxol

B-MS' BuSpar open to generic competition after lawsuit verdict?


Bristol-Myers Squibb has lost a lawsuit trying to block genericcompetition to its anxiolytic drug BuSpar…

Bristol-Myers SquibbBusparBuspironeMylan LaboratoriesWatson Pharmaceuticals

1 to 9 of 20 results

Back to top